Sei Investments Co. Has $1.63 Million Holdings in Heartflow, Inc. $HTFL

Posted by Francis Steltz on Aug 11th, 2026

Sei Investments Co. increased its holdings in shares of Heartflow, Inc. (NASDAQ:HTFL – Free Report) by 342.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 67,048 shares of the company’s stock after acquiring an additional 51,895 shares during the period. Sei Investments Co.’s holdings in Heartflow were worth $1,631,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wellington Management Group LLP acquired a new position in shares of Heartflow during the 3rd quarter worth about $164,263,000. Schusterman Interests LLC acquired a new stake in shares of Heartflow in the third quarter valued at about $65,274,000. Capricorn Investment Group LLC bought a new stake in Heartflow during the fourth quarter worth about $48,178,000. Vanguard Group Inc. acquired a new position in Heartflow during the third quarter valued at approximately $48,871,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Heartflow in the fourth quarter valued at approximately $41,714,000.

Heartflow Stock Up 1.8%

Shares of NASDAQ:HTFL opened at $29.35 on Tuesday. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $41.22. The company’s 50 day moving average price is $28.74 and its two-hundred day moving average price is $27.76. The firm has a market cap of $2.53 billion and a PE ratio of -9.44.

Heartflow (NASDAQ:HTFL – Get Free Report) last released its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The company’s revenue was up 41.3% on a year-over-year basis. On average, research analysts expect that Heartflow, Inc. will post -0.82 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have commented on HTFL shares. Wells Fargo & Company increased their price target on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday. Canaccord Genuity Group reduced their price objective on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Stifel Nicolaus set a $40.00 price objective on shares of Heartflow in a research report on Wednesday, July 15th. Finally, Piper Sandler reaffirmed an “overweight” rating on shares of Heartflow in a report on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $36.57.

Get Our Latest Report on HTFL

Insider Activity at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $28.34, for a total value of $261,266.46. Following the completion of the transaction, the insider owned 78,731 shares of the company’s stock, valued at $2,231,236.54. This represents a 10.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares in the company, valued at approximately $16,027,725. The trade was a 7.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 93,243 shares of company stock valued at $2,891,879. 7.70% of the stock is owned by insiders.

Heartflow Company Profile

(Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.